Acadia Pharmaceuticals
ACAD
ACAD
162 hedge funds and large institutions have $2.33B invested in Acadia Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 57 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 160 → 162 (+2)
12% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 57
Holders
162
Holding in Top 10
7
Calls
$243M
Puts
$22.1M
Top Buyers
| 1 | +$43.7M | |
| 2 | +$32.2M | |
| 3 | +$16.8M | |
| 4 |
WC
Weatherbie Capital
Boston,
Massachusetts
|
+$14.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$14.1M |
Top Sellers
| 1 | -$52.1M | |
| 2 | -$26.5M | |
| 3 | -$17.9M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$15.9M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$13.3M |